Sign inGet started

Gilman Sydney A.

Insider CIK 1793016 · DMAC VP, Regulatory Affairs

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DMAC DiaMedica Therapeutics Inc A Award deriv2021-07-282021-07-2925,000— $025,000SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2020-06-012020-06-0217,500— $017,500SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2019-11-012019-11-0550,000— $050,000SEC↗